TABLE 4:
Finding | Control Subjects | Patients with ADEM | Patients with MS |
P Value |
|
---|---|---|---|---|---|
Patients with ADEM vs Patients with MS | Control Subjects vs Patients with MS | ||||
MTR (%) | 45.7 (2.3) | 43.7 (2.5) | 39.2 (3.2) | .005 | <.001 |
MTR peak height | 69.6 (27.7) | 67.8 (10.3) | 65.4 (14.9) | >.05 | >.05 |
MTR peak position (%) | 40.8 (2.3) | 39.0 (4.0) | 34.3 (2.6) | .008 | <.001 |
Note.—Data are the means; data in parentheses are the SDs. No significant difference between control subjects and patients with ADEM was found.